Results 251 to 260 of about 611,597 (310)

Preventing End-Stage Kidney Disease in Older Adults with Type 2 Diabetes Mellitus: Optimal Blood Pressure Targets. [PDF]

Diabetes Metab J
Yun JS, Ko SH.
europepmc   +1 more source

Kidney Replacement Therapy Sequences: Racial/Ethnic Disparities in End-Stage Kidney Disease Patients' 10-Year Treatment Histories. [PDF]

Kidney Med
Pessin L, Roberts MK, Gillespie A, Butler CR, Corradi A, Randrianasolo A, Daw J.   +6 more
europepmc   +1 more source

A Case of Siblings with End-Stage Kidney Disease and Retinal Degeneration Suggestive of Partial Alström Syndrome.

Nephron
Shinkawa K, Ishii A, Kimura T, Toriu N, Nakagawa N, Wada T, Sakai K, Endo S, Yokoi H, Matsubara T, Kosaki K, Kosugi S, Yanagita M.   +12 more
europepmc   +1 more source

Insomnia Among Patients with End-Stage Kidney Disease on Hemodialysis: Prevalence and Associated Factors - A Cross-Sectional Study in Vietnam. [PDF]

Int J Nephrol Renovasc Dis
Tran NMH, Dinh VNN, Dang TK, Hoang BB.
europepmc   +1 more source

Expansion and Marketing of Medicare Advantage to Persons With End-Stage Kidney Disease.

JAMA Netw Open
Brazier JF, Trivedi AN, Tyler DA, Shield RR, Gadbois EA.   +4 more
europepmc   +1 more source

Correction to: A clinical score to predict recovery in end-stage kidney disease due to acute kidney injury. [PDF]

Clin Kidney J
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diphenhydramine Use in End-Stage Kidney Disease

American Journal of Therapeutics, 2021
Background: Diphenhydramine is commonly used in patients with kidney disease and end-stage kidney disease (ESKD) for sleep, allergic reactions, itching, and dialysis treatment related complications, and misuse associated with diphenhydramine is also reported. Diphenhydramine's pharmacokinetics property is reviewed and discussed.
Timothy, Nguyen, Beatrice, Polyakova, John, Cerenzio, Josh Renzo, Ramilo   +3 more
openaire   +2 more sources

Cancer Screening in End-Stage Kidney Disease

Advances in Chronic Kidney Disease, 2021
The incidence of cancer is higher in patients with end-stage kidney disease (ESKD) than among the general population. Despite this, screening for cancer is generally not cost-effective and may worsen quality of life in these patients. This is due to high mortality rates (patients are not living long enough to reap the benefits of screening), the ...
Shayan Shirazian, Piotr Starakiewicz, Sheron Latcha   +2 more
openaire   +2 more sources

End‐stage kidney disease in Fiji

Internal Medicine Journal, 2019
AbstractBackgroundChronic kidney disease is now a leading cause of death in Fiji. The country lacks even basic statistics about the incidence of end‐stage kidney disease (ESKD) and presents significant challenges to conducting clinical research.AimTo estimate the incidence and characteristics of ESKD in Fijian adults.MethodsA retrospective cohort study
Amrish Krishnan, Yogeshni Chandra, Joji Malani, Shilpanjali Jesudason, Shaundeep Sen, Angus G. Ritchie   +5 more
openaire   +2 more sources